Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Equivalent Admissions # are a general measure used to indicate combined inpatient and outpatient volumes.
The historical rank and industry rank for Intuitive Surgical's Equivalent Admissions # or its related term are showing as below:
ISRG's Equivalent Admissions # is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: * Ranked among companies with meaningful Equivalent Admissions # only.
Intuitive Surgical Equivalent Admissions # Historical Data
* Premium members only.
The historical data trend for Intuitive Surgical's Equivalent Admissions # can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISRG vs BDX, MDLN, RMD: Equivalent Admissions # Comparison
For the Medical Instruments & Supplies subindustry, Intuitive Surgical's Equivalent Admissions #, along with its competitors' market caps and Equivalent Admissions # data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intuitive Surgical (ISRG) has a Equivalent Admissions # of 0.00 as of Jun. 2026. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Intuitive Surgical and its competitors.
Is Intuitive Surgical's Equivalent Admissions # too high?
Intuitive Surgical's current Equivalent Admissions # is 0.00. Overall, Intuitive Surgical has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intuitive Surgical's Equivalent Admissions # compare to BDX and MDLN?
Intuitive Surgical's Equivalent Admissions # of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equivalent Admissions # for a Medical Devices & Instruments company?
A good Equivalent Admissions # depends on the Medical Devices & Instruments industry context. However, Equivalent Admissions # should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equivalent Admissions # mean?
A high Equivalent Admissions # can signal that a stock is expensive relative to its fundamentals. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Intuitive Surgical and its competitors. Intuitive Surgical's current Equivalent Admissions # is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intuitive Surgical stock overvalued right now?
Based on GuruFocus' analysis, Intuitive Surgical (ISRG) is currently considered Significantly Undervalued. The stock's GF Value™ is $616.69, compared to a current price of $372.61 — trading 39.6% below its estimated fair value. The current Equivalent Admissions # is 0.00. Intuitive Surgical's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equivalent Admissions # calculated?
Equivalent Admissions # is calculated from a company's financial statements. For Intuitive Surgical (ISRG), the current Equivalent Admissions # is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intuitive Surgical (ISRG) Overvalued in 2026?
Based on GuruFocus' analysis, Intuitive Surgical stock appears to be undervalued.
The current stock price of $372.61 is trading 39.6% below its estimated GF Value™ of $616.69.
GuruFocus considers Intuitive Surgical to be Significantly Undervalued.
Key valuation signals for ISRG:
Equivalent Admissions #: 0.00
GF Value™: $616.69 vs. price of $372.61 (39.6% below fair value)
No single metric tells the full story. See the ISRG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
93GF Score
Get the complete analysis for ISRG
Equivalent Admissions # is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISRG has been successfully added to your 
